Poll: Is the New Prenatal Blood Test for Trisomy 21 a Good Thing?
A new prenatal blood test for trisomy 21 has been released in Europe, and it's targeted to women in their 12th week and beyond. Is it a good thing?
A new prenatal blood test for trisomy 21 has been developed for women in their 12th week and beyond who are at increased risk for carrying a fetus with Down Syndrome. The test, which is at least 95% accurate, has already been released in Europe by the German company LifeCodexx under the name PrenaTest. An international federation of Down Syndrome organizations appealed to the European Court of Human Rights to stop the release of the test, and some physicians and advocates are concerned that the test will lead to an increase of abortions.
The makers of the test encourage amniocentesis ad genetic counseling for any woman with a positive test result. Amniocentesis, which has been the primary method of detection for trisomy 21, has a 1% risk of fetal loss in the 16th week.
Online Poll
|
Online Survey
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
